跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCION
Approved
STANDARD
ROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCION
Santen Oy
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 30, 2025
Approval ID
b4cfa80af119cd39
Company
Santen Oy
Type
Standard
Approval Details
Approval Id
b4cfa80af119cd39
Drug Cima Aemps Name
ROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCION
Register Number
1201502001IP
Holder Company Name
Santen Oy
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/santen-oy
Authorization Date
2025-06-30
Dosage Form
COLIRIO EN SOLUCIÓN
Dose
50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Santen Oy
Company Detail Path
/organization/santen-oy
Company Information
Pharmaceutical Company Name
Santen Oy
Country Name
Finland
City Name
københavn ø,hovedstaden,country_dk
Address
Østbanegade 123
Website
http://www.santen.fi
Active Ingredients
NETARSUDIL MESILATO
0,2849 mg
LATANOPROST
0,05 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 30, 2025
Approval ID
b4cfa80af119cd39
Type
Standard
Back to CIMA-AEMPS Approvals